Indications and uses
■ Hair loss relief treatment contains Centipeda Minima extract, an ingredient that provides prevent and alleviate hair loss and maintain your healthy hair roots.
ANACELL
- Manufacturer
- D-Nature Co., Ltd.
- Effective date
- 2021-07-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 23:41:16
Label at a glance#
ProductANACELL
Active ingredientCENTIPEDA MINIMA WHOLE
Label structure10 sections
Dosage and administration
After shampooing hair, dry it well and shaking the product sufficiently, apply an appropriate amount evenly to the scalp and rub it to absorb enough. The best usage time is 3 to 8 hours. Do not use for more than 8 hours. Wash off with shampoo after use. **Use the electric vibration hair massage device to maximize results. (5 to 10 minutes)**
Label contents#
Full prescribing information#
ACTIVE INGREDIENT
CENTIPEDA MINIMA WHOLE 47.5%
INACTIVE INGREDIENTS
PEG-8 Caprylic/Capric Glycerides, Ethoxydiglycol, Lecithin, Panthenol, Lavender Oil
PURPOSE
Anti hair loss
WARNINGS
For external use only.
In case of contact with eyes, wash immediately.
In case of using cosmetics or after use, please consult with a specialist if there is any abnormal symptom or side effect such as red spot, swelling, or itching by direct sunlight.
Please do not use the wound area.
Store at room temperature.
Keep out of direct sunlight.
Keep out of reach of children.
KEEP OUT OF REACH OF CHILDREN
KEEP OUT OF REACH OF CHILDREN
Uses
■ Hair loss relief treatment contains Centipeda Minima extract, an ingredient that provides prevent and alleviate hair loss and maintain your healthy hair roots.
Directions
After shampooing hair, dry it well and shaking the product sufficiently, apply an appropriate amount evenly to the scalp and rub it to absorb enough.
The best usage time is 3 to 8 hours.
Do not use for more than 8 hours.
Wash off with shampoo after use.
**Use the electric vibration hair massage device to maximize results. (5 to 10 minutes)**
QUESTIONS
CS phone number : +82-070-7545-1005
CS email : anacell@d-nature.co.kr
PACKAGE LABEL (Front)
PACKAGE LABEL (Back, Drug Facts)
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| QR code link | QR Code |  www.anacell.co.kr/ | anacell 2 carton.jpg |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 81823-010-02 | 2023-01-30 | C162847 | 48780-1 | f386c649-ea19-0266-e053-dadaa90a7c1a | cb4a730d-0b28-404a-93cb-d3cef932d860 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81823-010-01 | ANACELL | 1 mL in 1 CONTAINER | LIQUID | 1 | 1 | |
| 81823-010-02 | ANACELL | 30 in 1 CARTON | LIQUID | 30 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- ANACELL
- CENTIPEDA MINIMA WHOLE
- CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8
- DIETHYLENE GLYCOL MONOETHYL ETHER
- Panthenol
- LAVENDER OIL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 81823-010 | 81823-010-01, 81823-010-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CENTIPEDA MINIMA WHOLE | 7F196Q97IQ | ACTIB |
| CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8 | 00BT03FSO2 | IACT |
| DIETHYLENE GLYCOL MONOETHYL ETHER | A1A1I8X02B | IACT |
| Panthenol | WV9CM0O67Z | IACT |
| LAVENDER OIL | ZBP1YXW0H8 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2061f0b5-156a-4a86-9d0e-13c2d978e453 | cb4a730d-0b28-404a-93cb-d3cef932d860 | 2021-07-06 | Warnings | 2061f0b5-156a-4a86-9d0e-13c2d978e453 cb4a730d-0b28-404a-93cb-d3cef932d860 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.